User profiles for Aaron G. Schmidt
Aaron G. SchmidtHarvard Medical School Verified email at crystal.harvard.edu Cited by 18183 |
[PDF][PDF] mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
…, DJ Gregory, MC Poznansky, AG Schmidt… - Cell, 2022 - cell.com
Recent surveillance has revealed the emergence of the SARS-CoV-2 Omicron variant (BA.1/B.1.1.529)
harboring up to 36 mutations in spike protein, the target of neutralizing antibodies…
harboring up to 36 mutations in spike protein, the target of neutralizing antibodies…
[HTML][HTML] Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Vaccination elicits immune responses capable of potently neutralizing SARS-CoV-2. However,
ongoing surveillance has revealed the emergence of variants harboring mutations in …
ongoing surveillance has revealed the emergence of variants harboring mutations in …
[PDF][PDF] SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2
We show that SARS-CoV-2 spike protein interacts with both cellular heparan sulfate and
angiotensin-converting enzyme 2 (ACE2) through its receptor-binding domain (RBD). Docking …
angiotensin-converting enzyme 2 (ACE2) through its receptor-binding domain (RBD). Docking …
[PDF][PDF] SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues
There is pressing urgency to understand the pathogenesis of the severe acute respiratory
syndrome coronavirus clade 2 (SARS-CoV-2), which causes the disease COVID-19. SARS-…
syndrome coronavirus clade 2 (SARS-CoV-2), which causes the disease COVID-19. SARS-…
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
…, AG Schmidt, DR Wesemann, RS Baric, G Alter… - Science, 2020 - science.org
The global coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has made the development of a vaccine a top …
syndrome coronavirus 2 (SARS-CoV-2) has made the development of a vaccine a top …
[HTML][HTML] Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
…, H Andersen, MG Lewis, Y Cai, B Chen, AG Schmidt… - Nature, 2020 - nature.com
A safe and effective vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
may be required to end the coronavirus disease 2019 (COVID-19) pandemic 1 , 2 , 3 , 4 …
may be required to end the coronavirus disease 2019 (COVID-19) pandemic 1 , 2 , 3 , 4 …
[PDF][PDF] COVID-19-neutralizing antibodies predict disease severity and survival
…, JA Branda, JK Lennerz, D Lingwood, AG Schmidt… - Cell, 2021 - cell.com
Coronavirus disease 2019 (COVID-19) exhibits variable symptom severity ranging from
asymptomatic to life-threatening, yet the relationship between severity and the humoral immune …
asymptomatic to life-threatening, yet the relationship between severity and the humoral immune …
[PDF][PDF] Loss of Bcl-6-expressing T follicular helper cells and germinal centers in COVID-19
Humoral responses in coronavirus disease 2019 (COVID-19) are often of limited durability,
as seen with other human coronavirus epidemics. To address the underlying etiology, we …
as seen with other human coronavirus epidemics. To address the underlying etiology, we …
Immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women
…, J Liu, AG Schmidt, T Suscovich, C Linde, G Alter… - Jama, 2021 - jamanetwork.com
Importance Pregnant women are at increased risk of morbidity and mortality from COVID-19
but have been excluded from the phase 3 COVID-19 vaccine trials. Data on vaccine safety …
but have been excluded from the phase 3 COVID-19 vaccine trials. Data on vaccine safety …
SARS-CoV-2 infection protects against rechallenge in rhesus macaques
…, JP Nkolola, AG Schmidt, AD Miller, RS Baric, G Alter… - Science, 2020 - science.org
An understanding of protective immunity to severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) is critical for vaccine and public health strategies aimed at ending the global …
(SARS-CoV-2) is critical for vaccine and public health strategies aimed at ending the global …